We report the development of techniques for the genetic mapping of point mutations in the bacterial pathogen Bordeteiks pertussis. A plasmid vector which is self-transmissible by conjugation and which, by insertion into the B. pertussis chromosome, can mobilize chromosomal sequences during conjugation with a recipient B. pertussis bacterium has been constructed. This vector is used in conjunction with a set of strains containing kanamycin resistance gene insertions at defined physical locations in the B. pertussis genome. In crosses between these donor strains and a mutant recipient strain, transfer of a chromosomal segment flanking the kanamycin resistance gene insertion is selected for, and the percentage of exconjugants which reacquire the wild-type trait is scored. In this way the linkage of the mutant allele to these markers, and thus the approximate chromosomal position of the mutant allele, is determined. We have used this genetic system to map a newly described locus in B. pertussis involved in the regulation of the virulence genes ptx (pertussis toxin) and cya (adenylate cyclase toxin).
The genetic analysis of Escherichia coli may be said to have begun nearly 50 years ago upon the discovery of genetic transfer in this species, and it has continued unabated ever since (16) . In contrast, the genetic analysis of most other bacteria, including pathogenic bacteria, lacking genetic tools such as Hfr mapping and bacteriophage transduction, has had to await the development of newer techniques. The molecular biology revolution has given us the ability to clone genes from virtually any bacterium and to analyze their primary structure by DNA sequence analysis. However, an equally great impact has been made by the development of new genetic tools in the form of bacterial transposable elements, both those which are naturally occurring and those which have been engineered to have special characteristics.
The great power of transposons as mutagenic agents lies in (i) the ability to directly select for mutations by selecting for transposition events, (ii) the ability to easily clone genes which have been identified by transposon insertion by virtue of the linkage of a selectable marker to those genes, (iii) the ability to easily map the sites of such mutations physically by virtue of the physical nature of the insertion mutations created, and (iv) the ability to introduce gene fusions in order to identify genes regulated in a particular fashion or encoding proteins directed to a particular subcellular compartment.
By their nature transposon-induced mutations are usually "knock-outs" that completely destroy the function of the genes they identify. They thus cannot be used to identify essential genes and cannot generally be used in the isolation of secondsite suppressor mutations. This characteristic has not been a major drawback in the study of bacterial pathogens, as many of these efforts have been directed at the identification of virulence genes which are usually dispensable for a bacterium's viability when grown in vitro. However, in the case of some bacterial pathogens, our increasing knowledge and under-standing of their pathogenesis has led us to ask increasingly subtle or detailed questions. In these cases, it would be advantageous to be able to work routinely with missense and nonsense mutations. This requires an ability to map such mutations genetically, as the physical changes associated with such mutations are undetectable under most conditions. To this end we have developed tools which allow the genetic mapping of mutations in the human bacterial pathogen Bordetella pertussis.
B. pertussis is a dramatic demonstration of a phenomenon now seen as common in pathogenic bacteria, the regulation of virulence potential in response to environmental signals. In this organism, all known protein virulence factors are regulated by a single genetic locus discovered by transposon mutagenesis and known as bvg (previously vir) (29) . The bvg locus encodes two genes, bvgA and bvgS, which encode proteins belonging to the receiver or response regulator class and the transmitter or sensor class, respectively, of two-component regulatory systems of bacteria (1, 25, 28) . At least one virulence factor, an adhesin, the filamentous hemagglutin, is regulated directly by the bvg locus. This judgment comes from the observations that cloning bvg and fha together in E. coli reconstitutes expression of filamentous hemagglutinin in response to the correct environmental signals and from biochemical studies showing direct interaction between BvgA and the fJa promoter (18, 21, 27) . For other virulence genes, such as ptr, encoding pertussis toxin, and cya, encoding adenylate cyclase toxin, this regulation appears to be indirect or to occur by a different mechanism. Efforts to reconstitute expression of ptx or cya in E. coli have met with failure (8, 18) . A recent report suggests that bvg-dependent expression ofptx is possible under some conditions, but in this case responsiveness to environmental signals is not seen (22 conferring the phenotype expected of mutations identifying MATERUILS AND METHODS such a factor (Ptx-Cya-Fha+) have been reported (5, 9) . In Bacterial strains, plasmids, and media. Bacterial strains and this study we report the genetic mapping of these mutations in plasmids used in this study are presented in Table 1 . E. coli B. pertussis, with the finding that they identify a new locus in DH5o, which was used as a transformation host for all cloning this organism which is distinct from pix, cya, fha, and bvg. The B. pertussis strains BC7501 and RPV4 were spontaneous kasugamycin-resistant derivatives of BC7500 and RPV3, respectively, obtained by selection on Bordet-Gengou agar containing 200 pug of kasugamycin per ml. BC7502 and RPV5 were spontaneous rifampin-resistant derivatives of BC7500 and RPV3, respectively, selected on Bordet-Gengou agar containing 100 pug of rifampin per ml. BP1000 was isolated in an identical fashion. BP1087 was isolated in two steps, to rifampin resistance in a manner similar to that described above and to kasugamycin resistance by selection on Bordet-Gengou agar containing 200 jig of kasugamycin per ml. B. pertussis strains were grown on Bordet-Gengou agar (Difco) containing 1% proteose peptone (Difco) and 15% defibrinated sheep blood. Concentrations of antibiotics were as follows: gentamicin sulfate, 10 ,ug/ml; kanamycin sulfate, 10 ,ug/ml; 100 kasugamycin-HCl, 100 jig/ml; nalidixic acid, 50 jg/ml; rifampin, 50 jig/ml; and streptomycin sulfate, 100 jig/ml. E. coli strains were grown on L agar or in L broth (19) supplemented with antibiotics as appropriate. Concentrations of antibiotics were as follows: ampicillin, 100 ,ug/ml; gentamicin sulfate, 10 ,ug/ml; and kanamycin sulfate, 10 ,ug/ml.
Construction of pSS1853. PCR was used to generate a DNA fragment encoding gentamicin resistance. The sequence of the upstream primer was 5'-CGCGAATTICCACCGTGGAAAC GGATGAAGGCACG-3', and the sequence of the downstream primer was 5'-CGCGGATCCAAGC1TYlAGGTG GCGGTACTLGGGTCGATA-3'. The template DNA was pSS1129, which encodes a gentamicin acetyltransferase. After digestion of the PCR product with EcoRI and BamHI, a 798-bp fragment which extends from 38 bp upstream of the reported promoter of this gene to just past the reported stop codon (30) fragment of pSS1840 with EcoRI-and Sall-digested pSS1832, followed by in vitro packaging and transduction of gentamicin and ampicillin resistance. A map of pSS1853 is shown in Fig. 1 .
Construction of B. pertussis Hfr donor pools. The construction ofB. pertussis BP953 will be described elsewhere (24) . This strain is nalidixic acid resistant and streptomycin resistant, and it harbors two gene fusions: flaB-lacZ and ptx-phoA. A set of eleven insertions of a kanamycin resistance gene at different locations in the BP953 chromosome was constructed by using the linking plasmids and methods described previously (26) . These insertions were named BP953:K1 through BP953:K11, and their positions are shown graphically in Fig. 2 . A library of random B. pertussis fragments in pSS1853 was constructed, using the strategy of Hung and Wensink (13) . Chromosomal DNA of BP965 was digested with the restriction enzyme BstYI, which recognizes and cleaves within the sequence R'GATCY, leaving a 4-bp 5' overhang. The ends were partially filled in with the Klenow fragment of DNA polymerase by using a-S-dATP and a-S-dGTP as substrates to prevent proofreading by the Klenow enzyme. In a similar fashion, the vector pSS1853 was digested with Sall (G'TC GAC) and the sticky ends were partially filled in, using a-S-dCTP and a-S-dTTP as substrates. This approach has the combined virtues of forcing insertions in the vector without allowing insertion of multiple fragments (13) . After Isolation of pSS1853-12 and pSS1853-42. Some defined donor strains having a single origin of transfer were isolated from the donor pools described above. The location of the pSS1853 insertion in these strains was mapped to a particular SpeI or XbaI restriction fragment by digestion of chromosomal DNA in agarose plugs and electrophoresis on pulsed-field gels as previously described (26) . Although the pSS1853 vector does not contain these sites, fragments into which it has been inserted become approximately 50 kb larger as a result of the insertion, thus enabling mapping of the site of insertion to a particular restriction map interval. These plasmids were then recovered from the B. pertussis strains after conjugation with E. coli DH5ot and selection for gentamicin resistance on L agar. Table 2 , and the presence of alkaline phosphatase activity was determined by colony lifts with nitrocellulose membranes as previously described (15).
13-Galactosidase activity was detected in an analogous fashion by using filters soaked in Z-buffer (19) to which 0.003% sodium dodecyl sulfate was added. Hemolysis was apparent on BordetGengou agar. For the data presented in Table 2 , 200 exconjugant colonies were scored for each phenotypic marker.
RESULTS
Construction of a plasmid vector for the mobilization of B. pertussis chromosomal sequences. Hfr strains of E. coli are genetic donors of chromosomal loci as a result of the integration of the F plasmid in the chromosome. By analogy, we created a derivative of the conjugative R plasmid RK2 which could be directed to insert into the chromosomes of B. pertussis strains and thus mobilize chromosomal sequences. This plasmid, pSS1853, is depicted in Fig. 1 , and the details of its construction are given above. This plasmid contains all necessary information encoded by RK2 to mediate cell-to-cell transfer, including oriT, the site of initiation of transfer. The RK2 vegetative origin of replication, oriV, has been deleted, and thus this plasmid is incapable of replication in B. pertussis. However, the inclusion of a ColEl-derived oriV enables its maintenance in E. coli. Following conjugative transfer to B. determined by incubation of colonies in the presence of X-Gal (5-bromo-4-chloro-3-indolyl-j-D-galactopyranoside). In the case ofptx, it was Pho+, which was determined by incubation of colonies in the presence of BCIP (5-bromo-4-chloro-3-P-Dindolylphosphate). The recipient strain in this mating was BP1087, which is rifampin resistant and kasugamycin resistant but which lacks both gene fusions. The linkages observed are presented in Table 2 . These linkages were in keeping with the known physical locations of these two loci as shown in Fig. 2 Table 2 , and the inferred locations of these loci on the B.
pertussis Tohama I map are shown in Fig. 2 These tools consist of a set of strains having selectable genetic markers at different locations in the B. pertussis genome and a plasmid vector capable of insertion into the B. pertussis chromosome and of mediating transfer of chromosomal sequences in a manner analogous to that of Hfr-mediated conjugation in E. coli. Insertion of this vector into a donor B. pertussis strain can be directed to a specific location and orientation or random locations in a pool of genetic donors. We have primarily used the latter method, which we term generalized conjugation. As with phage P1-mediated generalized transduction, linkage of two genetic markers can fail to occur in two ways. Either the fragment of the chromosome which is transferred can fail to contain both markers, or a genetic crossover can occur between the two markers. The probability of either of these events occurring increases as the separation of the markers increases, and thus genetic linkage serves as an inverse indicator of the physical distance between two markers.
We have used these techniques to map two mutations describing a new genetic locus in B. pertussis, one which is involved in the expression of B. pertussis toxin genes. The results we obtained suggest that this new locus is tightly linked to the B. pertussis locus conferring streptomycin resistance, which is expected to be an rpsL homolog. This map position proved accurate enough to direct molecular cloning efforts aimed specifically toward this part of the B. pertussis chromosome, which led to the successful cloning and DNA sequencing of these two alleles. Those results are described in the accompanying paper, in which it is shown that these mutant alleles affect the level of the a subunit of RNA polymerase and are thus alleles of rpoA (4) . It is worth noting that because of the nature of these particular alleles, previous efforts at random cloning by complementation had been unsuccessful.
It should also be noted that these methods have great utility in terms of strain construction. The current method of choice for introducing known genetic markers into B. pertussis strains is to cross them in by using conditionally counterselectable suicide vectors donated from E. coli strains (23) . This is a two-step process for markers for which there is not a selectable phenotype. However, since only one selection step and only one outgrowth of B. pertussis are required, using conjugation between B. pertussis strains can reduce by half, or by 3 to 5 days, the time required to introduce a marker as long as it is linked to a selectable marker. In this way the Kanr Strs derivatives BP1137 and BP1138 were isolated.
Clearly the methods we have reported can be refined. This would include the development of a more complete set of selectable markers at a greater number of locations on the B.
VOL. 176, 1994 on August 28, 2017 by guest http://jb.asm.org/ Downloaded from pertussis chromosome as well as a set of defined Hfr plasmids to allow the efficient transfer of specific regions of the genome. Efforts towards such refinements are currently under way. However, the results reported here show the overall feasibility and utility of such an approach. It is our hope that these tools will be used to further the genetic analysis and understanding of this fascinating bacterial pathogen.
